Time course of the effects of temocapril on cardiovascular structure and function in patients with essential hypertension

被引:7
作者
Takata, M [1 ]
Ueno, H [1 ]
Hirai, T [1 ]
Oh-Hashi, S [1 ]
Yasumoto, K [1 ]
Inoue, H [1 ]
机构
[1] Toyama Med & Pharmaceut Univ, Dept Internal Med 2, Toyama 9300194, Japan
关键词
left ventricular hypertrophy; vascular hypertrophy; arterial distensibility; angiotensin-converting enzyme inhibitor; essential hypertension;
D O I
10.1097/00005344-199910000-00013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate the time course of cardiovascular structural changes in patients with essential hypertension after angiotensin-converting enzyme (ACE) inhibition, we determined left ventricular structure, minimal vascular resistance in the forearm as an index of resistance vessel structure and stiffness beta of carotid artery in 15 essential hypertensive subjects during a placebo period and after 2, 6, and 12 months of temocapril treatment. Blood pressure decreased within 2 weeks, and the antihypertensive effects were noted throughout the 12-month administration period. Left ventricular mass index decreased significantly after 2 months (120 +/- 12 to 106 +/- 9 g/m(2); p < 0.01) and was normalized after 12 months (88 +/- 6 g/m(2)). Postischemic minimal vascular resistance in the forearm decreased gradually from 2.1 +/- 0.5 to 1.6 +/- 0.4 PRU at month 12 of temocapril treatment. In contrast, increased stiffness index beta of carotid artery was not altered during a I-year treatment period (11.4 +/- 4.9 to 11.6 +/- 3.8 at month 12 of treatment). These data indicated that the regression of structural changes of left ventricle and arterioles occurred gradually and progressively for 1-year treatment with ACE inhibition, but large arteries were not affected.
引用
收藏
页码:561 / 566
页数:6
相关论文
共 43 条
  • [1] Agabiti-Rosei E, 1994, J Cardiovasc Pharmacol, V24 Suppl A, pS37
  • [2] AGABITIROSEI E, 1991, J CARDIOVASC PHARM, V18, pS5, DOI 10.1097/00005344-199106185-00003
  • [3] BENETOS A, 1994, J HYPERTENS, V12, pS21
  • [4] CRUICKSHANK JM, 1992, J HUM HYPERTENS, V6, P85
  • [5] REGIONAL HETEROGENEITY OF ARTERIAL STRUCTURAL-CHANGES
    DAEMEN, MJAP
    DEMEY, JGR
    [J]. HYPERTENSION, 1995, 25 (04) : 464 - 473
  • [6] REVERSAL OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS - A METAANALYSIS OF 109 TREATMENT STUDIES
    DAHLOF, B
    PENNERT, K
    HANSSON, L
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (02) : 95 - 110
  • [7] DAHLOF B, 1992, AM J HYPERTENS, V5, P900
  • [8] REVERSAL OF CARDIAC AND LARGE ARTERY STRUCTURAL ABNORMALITIES INDUCED BY LONG-TERM ANTIHYPERTENSIVE TREATMENT WITH TRANDOLAPRIL
    DELUCA, N
    ROSIELLO, G
    LAMENZA, F
    RICCIARDELLI, B
    MARCHEGIANO, R
    VOLPE, M
    MARELLI, C
    TRIMARCO, B
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (12) : D52 - D59
  • [9] ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR HYPERTROPHY - COMPARISON TO NECROPSY FINDINGS
    DEVEREUX, RB
    ALONSO, DR
    LUTAS, EM
    GOTTLIEB, GJ
    CAMPO, E
    SACHS, I
    REICHEK, N
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (06) : 450 - 458
  • [10] Folkow B, 1995, J HYPERTENS, V13, P1546